Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2022 - 03 - 08 save search
SEC Filing: Form 8-K
Published: 2022-03-08 (Crawled : 00:00) - vynetherapeutics.com
VYNE | $2.65 14.22% 12.45% 380K
|
Health Technology
|
| O: 5.9%
H: 0.0%
C: 0.0%
Repare Therapeutics to Present Comprehensive Phase 1 Monotherapy Data From the Phase 1/2 TRESR RP-3500 Clinical Trial and SNiPDx Panel at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
RPTX 4 | $3.3 -1.79% -1.82% 73K
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: 0.0%
rp-3500 500 trial therapeutics phase 1 therapy phase 2 phase 3
Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
CNTX | $1.38 -2.13% -2.17% 37K
|
Health Technology
|
| O: 3.21%
H: 7.21%
C: 6.21%
therapeutics america ces research cancer
Omega Therapeutics to Present Preclinical Data for OTX-2002 at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
OMGA | $2.335 -0.21% -0.21% 200K
|
|
| O: 2.36%
H: 0.0%
C: 0.0%
otx-2002 america research therapeutics preclinical cancer pre-clinical
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
ADAG | $2.65 -2.63% 740
|
Manufacturing
|
| O: 1.25%
H: 8.84%
C: -2.24%
america pos research therapeutics presentation preclinical cancer antibody pre-clinical
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ENLV | News | $1.52 15.15% 13.16% 130K
|
Health Technology
|
| O: -0.6%
H: 6.29%
C: 2.84%
israel ces patent cel
Cognition Therapeutics Announces Participation in March Investment Conferences
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CGTX | News | $2.0 0.0% 110K
|
|
| O: -7.12%
H: 11.69%
C: 6.85%
conference therapeutics
Monopar to Present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
MNPR | $0.63 -3.08% -3.17% 39K
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: -6.13%
conference axim growth
Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BOLT | $1.19 7.21% 6.72% 150K
|
|
| O: 3.38%
H: 13.07%
C: 11.44%
program therapeutics preclinical iot pre-clinical
Anika Reports Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ANIK | $26.02 0.89% 0.88% 31K
|
Health Technology
|
| O: -6.05%
H: 0.0%
C: -8.8%
financial results report results
Sarepta Therapeutics Announces Fifth Year of Route 79, The Duchenne Scholarship Program
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: -0.92%
H: 5.82%
C: 4.39%
program therapeutics duchenne
Chinook Therapeutics to Present at Oppenheimer’s 32nd Annual Healthcare Conference
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 0.65%
H: 3.29%
C: 2.73%
health thc conference therapeutics
C4 Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CCCC | $6.47 -6.23% -6.65% 1M
|
Health Technology
|
| O: 5.67%
H: 11.76%
C: 9.1%
america research therapeutics cancer
Iovance Biotherapeutics to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: 2.21%
H: 6.63%
C: 5.78%
america research therapeutics cancer iot
Pasithea Therapeutics Announces Collaboration with The Glimpse Group
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
KTTA | $7.09 -1.19% 910
|
|
| O: -2.65%
H: 12.73%
C: 10.0%
announces collaboration therapeutics collaboration group
Nykode Therapeutics to Present at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 5.13%
H: 4.78%
C: 1.66%
america research therapeutics cancer
Rubius Therapeutics to Present Updated Results from Single-Agent Phase 1 Clinical Trial of RTX-240 at the American Association of Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 2.12%
H: 20.58%
C: 19.33%
rtx-240 america research trial therapeutics phase 1 results cancer
CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NKTX | $7.16 -5.29% -5.59% 680K
|
Health Technology
|
| O: 1.46%
H: 6.9%
C: 6.49%
CRSP | News 4 | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: 0.81%
H: 3.86%
C: 2.6%
america pos research therapeutics crispr presentation cancer
Nurix Therapeutics to Present Preclinical Data from Its Novel BTK Degrader (NX-2127) and CBL-B Inhibitor (NX-0255) Programs at the American Association for Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: 3.92%
H: 3.77%
C: 2.25%
nx-2127 america program research therapeutics preclinical cancer pre-clinical
Aquestive Therapeutics Reports Full Year 2021 Results Exceeding Revenue and EBITDA Guidance
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 1.12%
H: 0.0%
C: 0.0%
AQST | $3.905 -8.76% -9.6% 2.1M
|
Health Technology
|
| O: -5.32%
H: 9.93%
C: 4.87%
therapeutics report results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.